Endoscopic Devices - France | Statista Market Forecast

Revenue in the Endoscopic Devices market market in France is projected to reach US$1.18bn in 2024.
Revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 6.25%, leading to a market volume of US$1.60bn by 2029.
In a global context, the majority of revenue will be generated the United States, with an expected figure of US$10.39bn in 2024.
In France, the rising demand for minimally invasive surgeries is significantly driving innovation and investment in the endoscopic devices segment of the medical technology market.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in France is witnessing moderate growth, influenced by advancements in minimally invasive procedures, an aging population, and increasing demand for diagnostic and therapeutic solutions. Regulatory challenges and competition also shape this market landscape.

Customer preferences: Consumers in France are increasingly prioritizing minimally invasive procedures, reflecting a growing preference for quicker recovery times and reduced hospital stays. This trend is fueled by an aging population that values enhanced quality of life and less invasive treatment options. Additionally, there is a rising awareness of preventive healthcare, prompting individuals to seek out advanced diagnostic solutions. Cultural shifts towards health and wellness further emphasize the demand for innovative endoscopic devices that align with evolving lifestyle choices and healthcare needs.

Trends in the market: In France, the Endoscopic Devices Market is experiencing a surge in demand for advanced minimally invasive surgical technologies, driven by a combination of factors including an aging demographic and increased health consciousness. This shift towards less invasive procedures not only enhances patient comfort but also shortens recovery times, which is crucial for older populations. Additionally, there is a notable rise in investment in innovative endoscopic technologies, as healthcare providers aim to improve diagnostic accuracy and patient outcomes, ultimately influencing industry growth and competitive dynamics among medical device manufacturers.

Local special circumstances: In France, the Endoscopic Devices Market is shaped by a robust healthcare system that emphasizes high-quality patient care and innovative medical solutions. The country's stringent regulatory framework ensures that only the most effective and safe devices are approved, fostering trust among healthcare providers and patients. Additionally, France's strong emphasis on research and development has led to a thriving ecosystem for medical technology startups, promoting the creation of cutting-edge endoscopic devices. Cultural preferences for minimally invasive procedures further drive demand, as patients seek quicker recoveries and enhanced quality of life.

Underlying macroeconomic factors: The Endoscopic Devices Market in France is significantly influenced by macroeconomic factors such as national healthcare spending, technological innovation, and demographic trends. A strong national economy, supported by government investments in healthcare infrastructure, enhances the availability and adoption of advanced endoscopic technologies. Furthermore, France's aging population increases the prevalence of conditions requiring minimally invasive procedures, thus driving demand. Global economic trends, such as shifts towards value-based healthcare and rising consumer expectations for quality medical solutions, also play a crucial role in shaping market dynamics, encouraging continuous improvement in endoscopic device offerings.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.